{"id":135312,"date":"2026-01-14T08:45:08","date_gmt":"2026-01-14T08:45:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/135312\/"},"modified":"2026-01-14T08:45:08","modified_gmt":"2026-01-14T08:45:08","slug":"ny-mekanism-kopplar-epstein-barr-virus-till-ms","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/135312\/","title":{"rendered":"Ny mekanism kopplar Epstein-Barr-virus till MS"},"content":{"rendered":"<p>Bild:<\/p>\n<p> <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/01\/TomasOlsson,fotoAndreasAndersson_custom20260109091546.jpg\" alt=\"Professor Tomas Olsson\"\/><\/p>\n<p>Rubrik:<\/p>\n<p> Tomas Olsson.<br \/>\nFoto: Andreas Andersson<\/p>\n<p>\u2013 Uppt\u00e4ckten \u00f6ppnar f\u00f6r nya behandlingar som riktar in sig p\u00e5 dessa korsreaktiva immunceller. Eftersom flera EBV-vacciner och antivirala l\u00e4kemedel nu testas i kliniska pr\u00f6vningar kan resultaten vara av stor betydelse f\u00f6r framtida f\u00f6rebyggande och behandlande insatser, s\u00e4ger professor <a href=\"https:\/\/ki.se\/personer\/tomas-olsson\" data-entity-type=\"external\" rel=\"nofollow noopener\" target=\"_blank\">Tomas Olsson <\/a>som har lett studien tillsammans med docent Andre Ortlieb Guerreiro-Cacais vid samma institution.\u00a0<\/p>\n<p>Studien \u00e4r ett samarbete mellan flera forskargrupper vid Karolinska Institutet och har finansierats av bland annat Vetenskapsr\u00e5det, EU:s Horizon-program, Hj\u00e4rnfonden och Neurof\u00f6rbundet. Flera av artikelf\u00f6rfattarna har kopplingar till l\u00e4kemedelsbolag, se den vetenskapliga artikeln f\u00f6r en komplett f\u00f6rteckning \u00f6ver intressekonflikter.<\/p>\n<p><strong>Publikation<\/strong><\/p>\n<p><a href=\"https:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(25)01481-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867425014813%3Fshowall%3Dtrue\" data-entity-type=\"external\" rel=\"nofollow noopener\" target=\"_blank\">\u201dAnoctamin-2-specific T Cells Link Epstein-Barr Virus to Multiple Sclerosis\u201d,<\/a>\u00a0Olivia G. Thomas, Urszula Rykaczewska, Marina Gale\u0161i\u0107, Rianne T. M. van der Burgt, Nils Hall\u00e9n, Filippo Ferro, Mattias Bronge, Zoe Marti, Yue Li, Alexandra Hill Riqu\u00e9, Jianing Lin, Aleksa Krstic, Alicja Gromadzka, Andr\u00e1s Levente Szonder, Chiara Sorini, Mar\u00eda Reina-Campos, Ting Sun, Leslie A. Rubio Rodr\u00edguez-Kirby, \u00d6zge Dumral, Rasmus Berglund, Majid Pahlevan Kakhki, Milena Z. Adzemovic, Manuel Zeitelhofer, Birce Akpinar, Katarina Tengvall, Ola B. Nilsson, Erik Holmgren, Chiara Starvaggi Cucuzza, Klara Asplund H\u00f6gelin, Guro Gafvelin, Katharina Fink, Gon\u00e7alo Castelo-Branco, Maria Needhamsen, Mohsen Khademi, Fredrik Piehl, Torbj\u00f6rn Gr\u00e4slund, Lars Alfredsson, Harald Lund, Per Uhl\u00e9n, Ingrid Kockum, Roland Martin, Maja Jagodic, Hans Gr\u00f6nlund, Andr\u00e9 Ortlieb Guerreiro-Cacais, Tomas Olsson, Cell, online 13 januari 2026, doi: 10.1016\/j.cell.2025.12.032<\/p>\n","protected":false},"excerpt":{"rendered":"Bild: Rubrik: Tomas Olsson. Foto: Andreas Andersson \u2013 Uppt\u00e4ckten \u00f6ppnar f\u00f6r nya behandlingar som riktar in sig p\u00e5&hellip;\n","protected":false},"author":2,"featured_media":135313,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,34,31,33,32,30],"class_list":{"0":"post-135312","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-se","11":"tag-svenska","12":"tag-sverige","13":"tag-sweden","14":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115892579451021836","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/135312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=135312"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/135312\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/135313"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=135312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=135312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=135312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}